Selected research
Industry Growth & Trends
Global Flutamide Industry Growth and Trends Forecast to 2032
Market perspective
The global Flutamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Flutamide include Tasly Diyi Pharma, Forward, SANDOZ, Merck, TEVA Pharma, Florencia Healthcare, Cipla LifeScience and Actiza Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Flutamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Flutamide market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Flutamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Flutamide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Flutamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Flutamide Market by Company
Tasly Diyi Pharma
Forward
SANDOZ
Merck
TEVA Pharma
Florencia Healthcare
Cipla LifeScience
Actiza Pharma
Flutamide Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Flutamide Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Flutamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flutamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Flutamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flutamide Tablets
- Flutamide Capsule
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Tasly Diyi Pharma
- Forward
- SANDOZ
- Merck
- TEVA Pharma
- Florencia Healthcare
- Cipla LifeScience
- Actiza Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Flutamide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Flutamide Sales Estimates and Forecasts (2021-2032)
- 1.3 Flutamide Market by Type
- 1.3.1 Flutamide Tablets
- 1.3.2 Flutamide Capsule
- 1.3.3 Others
- 1.4 Global Flutamide Market Size by Type
- 1.4.1 Global Flutamide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Flutamide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Flutamide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Flutamide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Flutamide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Flutamide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Flutamide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Flutamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Flutamide Industry Trends
- 2.2 Flutamide Industry Drivers
- 2.3 Flutamide Industry Opportunities and Challenges
- 2.4 Flutamide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Flutamide Revenue (2021-2026)
- 3.2 Global Top Players by Flutamide Sales (2021-2026)
- 3.3 Global Top Players by Flutamide Price (2021-2026)
- 3.4 Global Flutamide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Flutamide Major Company Production Sites & Headquarters
- 3.6 Global Flutamide Company, Product Type & Application
- 3.7 Global Flutamide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Flutamide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Flutamide Players Market Share by Revenue in 2025
- 3.8.3 2025 Flutamide Tier 1, Tier 2, and Tier 3
4 Flutamide Regional Status and Outlook
- 4.1 Global Flutamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Flutamide Historic Market Size by Region
- 4.2.1 Global Flutamide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Flutamide Sales in Value by Region (2021-2026)
- 4.2.3 Global Flutamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Flutamide Forecasted Market Size by Region
- 4.3.1 Global Flutamide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Flutamide Sales in Value by Region (2027-2032)
- 4.3.3 Global Flutamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Flutamide by Application
- 5.1 Flutamide Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Flutamide Market Size by Application
- 5.2.1 Global Flutamide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Flutamide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Flutamide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Flutamide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Flutamide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Flutamide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Flutamide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Flutamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Tasly Diyi Pharma
- 6.1.1 Tasly Diyi Pharma Company Information
- 6.1.2 Tasly Diyi Pharma Business Overview
- 6.1.3 Tasly Diyi Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Tasly Diyi Pharma Flutamide Product Portfolio
- 6.1.5 Tasly Diyi Pharma Recent Developments
- 6.2 Forward
- 6.2.1 Forward Company Information
- 6.2.2 Forward Business Overview
- 6.2.3 Forward Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Forward Flutamide Product Portfolio
- 6.2.5 Forward Recent Developments
- 6.3 SANDOZ
- 6.3.1 SANDOZ Company Information
- 6.3.2 SANDOZ Business Overview
- 6.3.3 SANDOZ Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 SANDOZ Flutamide Product Portfolio
- 6.3.5 SANDOZ Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Merck Flutamide Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 TEVA Pharma
- 6.5.1 TEVA Pharma Company Information
- 6.5.2 TEVA Pharma Business Overview
- 6.5.3 TEVA Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 TEVA Pharma Flutamide Product Portfolio
- 6.5.5 TEVA Pharma Recent Developments
- 6.6 Florencia Healthcare
- 6.6.1 Florencia Healthcare Company Information
- 6.6.2 Florencia Healthcare Business Overview
- 6.6.3 Florencia Healthcare Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Florencia Healthcare Flutamide Product Portfolio
- 6.6.5 Florencia Healthcare Recent Developments
- 6.7 Cipla LifeScience
- 6.7.1 Cipla LifeScience Company Information
- 6.7.2 Cipla LifeScience Business Overview
- 6.7.3 Cipla LifeScience Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Cipla LifeScience Flutamide Product Portfolio
- 6.7.5 Cipla LifeScience Recent Developments
- 6.8 Actiza Pharma
- 6.8.1 Actiza Pharma Company Information
- 6.8.2 Actiza Pharma Business Overview
- 6.8.3 Actiza Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Actiza Pharma Flutamide Product Portfolio
- 6.8.5 Actiza Pharma Recent Developments
7 North America by Country
- 7.1 North America Flutamide Sales by Country
- 7.1.1 North America Flutamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Flutamide Sales by Country (2021-2026)
- 7.1.3 North America Flutamide Sales Forecast by Country (2027-2032)
- 7.2 North America Flutamide Market Size by Country
- 7.2.1 North America Flutamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Flutamide Market Size by Country (2021-2026)
- 7.2.3 North America Flutamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Flutamide Sales by Country
- 8.1.1 Europe Flutamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Flutamide Sales by Country (2021-2026)
- 8.1.3 Europe Flutamide Sales Forecast by Country (2027-2032)
- 8.2 Europe Flutamide Market Size by Country
- 8.2.1 Europe Flutamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Flutamide Market Size by Country (2021-2026)
- 8.2.3 Europe Flutamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Flutamide Sales by Country
- 9.1.1 Asia-Pacific Flutamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Flutamide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Flutamide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Flutamide Market Size by Country
- 9.2.1 Asia-Pacific Flutamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Flutamide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Flutamide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Flutamide Sales by Country
- 10.1.1 South America Flutamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Flutamide Sales by Country (2021-2026)
- 10.1.3 South America Flutamide Sales Forecast by Country (2027-2032)
- 10.2 South America Flutamide Market Size by Country
- 10.2.1 South America Flutamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Flutamide Market Size by Country (2021-2026)
- 10.2.3 South America Flutamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Flutamide Sales by Country
- 11.1.1 Middle East and Africa Flutamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Flutamide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Flutamide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Flutamide Market Size by Country
- 11.2.1 Middle East and Africa Flutamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Flutamide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Flutamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Flutamide Value Chain Analysis
- 12.1.1 Flutamide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Flutamide Production Mode & Process
- 12.2 Flutamide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Flutamide Distributors
- 12.2.3 Flutamide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst